| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tetratricopeptide repeat domain 8 | 0.631 | 0.500 | 1.2E-06 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
LDL receptor related protein 4 | 0.568 | 0.692 | 1.4E-06 |
|
disease | 0.300 | strong | 0 | 0 | |||||||||||
|
intraflagellar transport 52 | 0.653 | 0.538 | 2.0E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
centrosomal protein 41 | 0.636 | 0.500 | 3.6E-06 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
Bardet-Biedl syndrome 5 | 0.659 | 0.577 | 4.8E-06 |
|
disease | 0.300 | strong | 0 | 0 | |||||||||||
|
intraflagellar transport 27 | 0.670 | 0.462 | 5.9E-06 |
|
disease | 0.400 | moderate | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ciliogenesis associated kinase 1 | 0.545 | 0.808 | 1.3E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.300 | strong | 0 | 0 | |||||||||||
|
multiple EGF like domains 8 | 0.584 | 0.538 | 1.9E-05 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
B9 domain containing 2 | 0.606 | 0.577 | 5.3E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
cytoskeleton associated protein 2 like | 0.666 | 0.577 | 1.6E-04 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
Tctex1 domain containing 2 | 0.751 | 0.346 | 3.2E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
serine peptidase inhibitor, Kunitz type 2 | 0.556 | 0.808 | 7.5E-04 |
|
disease | 0.300 | moderate | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
tripartite motif containing 32 | 0.587 | 0.769 | 1.7E-03 |
|
disease | 0.400 | limited | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
transmembrane protein 216 | 0.544 | 0.615 | 1.9E-03 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
sterol-C5-desaturase | 0.641 | 0.577 | 2.6E-03 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
B9 domain containing 1 | 0.572 | 0.692 | 2.8E-03 |
|
disease | 0.410 | limited | 1.000 | 1 | 0 | 2011 | 2014 | ||||||||
|
inositol polyphosphate-5-phosphatase E | 0.561 | 0.615 | 3.1E-03 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2015 | 2017 | ||||||||
|
RAB23, member RAS oncogene family | 0.541 | 0.654 | 5.6E-03 |
|
disease | 0.300 | strong | 0 | 0 | |||||||||||
|
phosphodiesterase 6D | 0.623 | 0.577 | 6.4E-03 |
|
disease | 0.300 | moderate | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
homeobox D13 | 0.483 | 0.808 | 8.6E-03 |
|
disease | 0.450 | strong | 0.833 | 1 | 0 | 1995 | 2017 | ||||||||
|
SPARC related modular calcium binding 1 | 0.565 | 0.846 | 9.5E-03 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ADP ribosylation factor like GTPase 6 | 0.636 | 0.462 | 1.0E-02 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
phosphoinositide-3-kinase regulatory subunit 2 | 0.551 | 0.808 | 1.6E-02 |
|
disease | 0.300 | strong | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
ALX homeobox 3 | 0.578 | 0.692 | 1.9E-02 |
|
disease | 0.300 | limited | 0 | 0 |